Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer

被引:10
|
作者
Cheng, David [1 ,2 ]
Dumontier, Clark [2 ,3 ,4 ]
Sheikh, Ayesha R. [5 ]
La, Jennifer [3 ]
Brophy, Mary T. [3 ,6 ]
Do, Nhan, V [3 ,6 ]
Driver, Jane A. [2 ,3 ,6 ,7 ]
Tuck, David P. [3 ,6 ]
Fillmore, Nathanael R. [2 ,3 ,7 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] VA Boston Healthcare Syst, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
[5] St Vincent Hosp, Worcester, MA 01604 USA
[6] Boston Univ, Boston, MA 02215 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
来源
CANCER MEDICINE | 2022年 / 11卷 / 15期
关键词
electronic health records; frailty; non-small cell lung; prognosis; veterans; COMPREHENSIVE GERIATRIC ASSESSMENT; CARE; ONCOLOGY; ACCUMULATION; MORTALITY; CONSENSUS; SURVIVAL; CURVES; ADULTS;
D O I
10.1002/cam4.4658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Older patients with non-small cell lung cancer (NSCLC) are a heterogeneous population with varying degrees of frailty. An electronic frailty index such as the Veterans Affairs Frailty Index (VA-FI) can potentially help identify vulnerable patients at high risk of poor outcomes. Methods NSCLC patients >= 65 years old and diagnosed in 2002-2017 were identified using the VA Central Cancer Registry. The VA-FI was calculated using administrative codes from VA electronic health records data linked with Medicare and Medicaid data. We assessed associations between the VA-FI and times to mortality, hospitalization, and emergency room (ER) visit following diagnosis by Kaplan-Meier analysis and multivariable stratified Cox models. We also evaluated the change in discrimination and calibration of reference prognostic models after adding VA-FI. Results We identified a cohort of 42,204 older NSCLC VA patients, in which 55.5% were classified as frail (VA-FI >0.2). After adjustment, there was a strong association between VA-FI and the risk of mortality (HR = 1.23 for an increase of four deficits or, equivalently, an increase of 0.129 on VA-FI, p < 0.001), hospitalization (HR = 1.16 for four deficits, p < 0.001), and ER visit (HR = 1.18 for four deficits, p < 0.001). Adding VA-FI to baseline prognostic models led to statistically significant improvements in time-dependent area under curves and did not have a strong impact on calibration. Conclusion Older NSCLC patients with higher VA-FI have significantly elevated risks of mortality, hospitalizations, and ER visits following diagnosis. An electronic frailty index can serve as an accessible tool to identify patients with vulnerabilities to inform clinical care and research.
引用
收藏
页码:3009 / 3022
页数:14
相关论文
共 50 条
  • [21] Clinical prognostic model for older patients with advanced non-small cell lung cancer
    Ganti, Apar Kishor
    Wang, Xiaofei
    Stinchcombe, Thomas E.
    Wang, Yinpeng
    Bradley, Jeffrey
    Cohen, Harvey J.
    Kelly, Karen
    Paulus, Rebecca
    Ramalingam, Suresh S.
    Vokes, Everett E.
    Pang, Herbert
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (04) : 555 - 559
  • [22] TREATMENT OF ELDERLY NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS - A PROGNOSTIC INDEX
    Clement, D.
    Marinca, M.
    Miron, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 209 - 209
  • [23] The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer
    Liu, Xiao-Yue
    Zhang, Xi
    Zhang, Qi
    Ruan, Guo-Tian
    Liu, Tong
    Xie, Hai-Lun
    Ge, Yi-Zhong
    Song, Meng-Meng
    Deng, Li
    Shi, Han-Ping
    SUPPORTIVE CARE IN CANCER, 2023, 31 (09)
  • [24] A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
    Ulas, Arife
    Turkoz, Fatma Paksoy
    Silay, Kamile
    Tokluoglu, Saadet
    Avci, Nilufer
    Oksuzoglu, Berna
    Alkis, Necati
    PLOS ONE, 2014, 9 (12):
  • [25] The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer
    Xiao-Yue Liu
    Xi Zhang
    Qi Zhang
    Guo-Tian Ruan
    Tong Liu
    Hai-Lun Xie
    Yi-Zhong Ge
    Meng-Meng Song
    Li Deng
    Han-Ping Shi
    Supportive Care in Cancer, 2023, 31
  • [26] Prognostic value of microRNA expression in operable non-small cell lung cancer patients
    Skrzypski, M.
    Czapiewski, P.
    Goryca, K.
    Jassem, E.
    Wyrwicz, L.
    Pawlowski, R.
    Rzyman, W.
    Biernat, W.
    Jassem, J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 991 - 1000
  • [27] Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
    Kim, Anthony W.
    Batus, Marta
    Myint, Ronald
    Fidler, Mary J.
    Basu, Sanjib
    Bonomi, Philip
    Faber, L. Penfield
    Wightman, Sean C.
    Warren, William H.
    McIntire, Maria
    Arvanitis, Leonidas D.
    Gattuso, Paolo
    Xue, Xiulong
    Liptay, Michael J.
    LUNG CANCER, 2011, 71 (02) : 186 - 190
  • [28] Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer
    Xu, Chun-Hua
    Wang, Wei
    Lin, Yong
    Qian, Li-Hua
    Zhang, Xiu-Wei
    Wang, Qing-Bo
    Yu, Li-Ke
    ONCOTARGET, 2017, 8 (12) : 18746 - 18753
  • [29] Prognostic value of microRNA expression in operable non-small cell lung cancer patients
    M Skrzypski
    P Czapiewski
    K Goryca
    E Jassem
    L Wyrwicz
    R Pawłowski
    W Rzyman
    W Biernat
    J Jassem
    British Journal of Cancer, 2014, 110 : 991 - 1000
  • [30] Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer
    Jiang, Ai-Gui
    Chen, Hong-Lin
    Lu, Hui-Yu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (03) : 563 - 568